Kanagawa Cancer Center announces new sepsis treatment

Kanagawa Cancer Center announces new sepsis treatment

Makoto Akaike (R), chief of the Kanagawa Cancer Center, and Kozo Imai, director of the center's clinical research institute, announce a new treatment method for sepsis at a press conference in Yokohama, southwest of Tokyo, on March 24, 2015. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000066311
  • Registered date
  • 2015/3/24 20:57:02
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1614 × 1424 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 197.96(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    World's 1st transplant performed of retinal cells from another's iPS cells

    World's 1st transplant performed of retinal cells from another's iPS cells

    Masayo Takahashi (R), a researcher at Riken institute, and Yasuo Kurimoto, an eye doctor at Kobe City Medical Center General Hospital, attend a press conference in the western Japan city of Kobe on March 28, 2017, after performing a pioneering transplant surgery utilizing so-called induced pluripotent stem cells, or iPS cells, to treat an older man suffering from wet-type age-related macular degeneration. (Kyodo) ==Kyodo
      World's 1st transplant performed of retinal cells from another's iPS cells

      World's 1st transplant performed of retinal cells from another's iPS cells

      Masayo Takahashi (R), a researcher at Riken institute, and Yasuo Kurimoto, an eye doctor at Kobe City Medical Center General Hospital, attend a press conference in the western Japan city of Kobe on March 28, 2017, after performing a pioneering transplant surgery utilizing so-called induced pluripotent stem cells, or iPS cells, to treat an older man suffering from wet-type age-related macular degeneration. (Kyodo) ==Kyodo
        World's 1st transplant performed of retinal cells from another's iPS cells

        World's 1st transplant performed of retinal cells from another's iPS cells

        Masayo Takahashi (R), a researcher at Riken institute, and Yasuo Kurimoto, an eye doctor at Kobe City Medical Center General Hospital, attend a press conference in the western Japan city of Kobe on March 28, 2017, after performing a pioneering transplant surgery utilizing so-called induced pluripotent stem cells, or iPS cells, to treat an older man suffering from wet-type age-related macular degeneration. (Kyodo) ==Kyodo
          World's 1st transplant performed of retinal cells from another's iPS cells

          World's 1st transplant performed of retinal cells from another's iPS cells

          Masayo Takahashi (R), a researcher at Riken institute, and Yasuo Kurimoto, an eye doctor at Kobe City Medical Center General Hospital, attend a press conference in the western Japan city of Kobe on March 28, 2017, after performing a pioneering transplant surgery utilizing so-called induced pluripotent stem cells, or iPS cells, to treat an older man suffering from wet-type age-related macular degeneration. (Kyodo) ==Kyodo